• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL attends event on Clinical trial strategy

SFL’s Director of Regulatory Affairs Suzanne Einmahl and Director of Medical Affairs Daniela Kenzelmann Broz will attend the Swiss Biotech Insight event on “Clinical trial strategy: Fine-tuning the risk-reward profile” (19 September 2019, Lausanne). The event hosts speakers discussing strategies in developing innovative clinical products from idea to proof-of-concept, harnessing new technologies in drug development, changing regulatory frameworks and future opportunities in drug development.

SFL provides both strategic as well as operational support for projects covering all life-cycle stages from early development to regulatory maintenance and commercialization of approved healthcare products, utilizing its unique combination of expertise and a multi-disciplinary approaContact us to arrange a meeting to discuss how SFL can support your projects.

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top